Beyond the Broadcast: Expert Insights on SGLT2 Inhibitors in Cardiometabolic Care
- Author
- ReachMD
- Published
- Tue 04 Feb 2025
- Episode Link
- http://reachmd.com/programs/cme/beyond-the-broadcast-expert-insights-on-sglt2-inhibitors-in-cardiometabolic-care/29104/
CME credits: 0.25
Valid until: 04-02-2026
Claim your CME credit at https://reachmd.com/programs/cme/beyond-the-broadcast-expert-insights-on-sglt2-inhibitors-in-cardiometabolic-care/29104/
Valid until: 04-02-2026
Claim your CME credit at https://reachmd.com/programs/cme/beyond-the-broadcast-expert-insights-on-sglt2-inhibitors-in-cardiometabolic-care/29104/
Are you up to date on the plethora of benefits patients may receive from SGLT2 inhibitors? Learn from a multidisciplinary faculty panel as they use patient case vignettes to review emerging evidence and evolving treatment guidelines related to cardio-renal-metabolic comorbidities such as type 2 diabetes, heart failure, chronic kidney disease, and management of patients post-MI. Tune in for the insights you need to enhance your practice.
=